lending further support to the possibility that the phenomenon may be a factor in the pathogenesis of the rheumatic attack.
Decreases in serum complement are known to occur when there are present in the circulation both an antigen and its antibody, with the former in excess. This suggested that during phase II, when complement is diminished an excess of some antigen might be present. Should such an antigen occur, its antibody should then be present in excess shortly after the return of complement to normal, that is in the course of phase III. We have therefore looked for evidence of both antigen and antibody in the form of mutual precipitation between sera of phase III (presumptive antibody) and sera from phases II and I (presumptive antigen).
EXPER~NTAL PROCEDURE
Selection of Pa~ients.--Serial blood samples were taken at least once a week from rheumatic subjects recovering from hemolytic streptococcus pharyngitis, and from non-rheumatic controls. Single blood samples were taken from control patients with other febrile disease and from individuals in good health.
Preparation of Sera.--Sera were preserved with merthiolate and stored at 5°C. for periods up to 6 months. Before being tested, they were cleared by high speed centrifugafion and, when necessary, by filtration through a Pasteur-Chamberland candle L2.
The Precipitin Test.--Chemically clean precipitin tubes and pipettes were used exclusively. Undiluted sera were tested against one another for mutual precipitation. 0.1 ce. of antibody serum was layered over 0.1 cc. of antigen serum. Three readings were recorded as follows, the third being the one reported throughout this paper: (a) Ring formation after 10 minutes at room temperature. (b) Precipitation after mixing and incubation for 2 hours in a 37 ° water bath. (c) Precipitation after refrigeration overnight at 5°C. The intensity of precipitation is expressed as in previous communications (10) . + + + large flakes. + + ± large and small flakes. + + small flakes or granules supernatant clear. + ± numerous flakes or granules appearing in cloudy whirl. + cloudy whirl. 0 clear.
-not tested.
Preliminary Observations
It was soon observed that sera taken at the height of an acute attack showed definite precipitation with sera taken within a week before the onset of symptoms. Pairs of sera which reacted with each other were then tested separately against other sera from the same patient, as tabulated in the following sample protocol. These findings showed that precipitation occurred only between phase II and phase III sera. In at least six other patients known positive phase II sera were tested against each other and known positive phase III sera were also tested in pairs. No reactions occurred between any of these combinations. This limitation of the reaction to the combination of phases II and III furnished a plan on which extensive investigations were based. Sera from phase II (and also, when available, from phase I) were tested as potential antigens against sera from phase III.
Precipitin Reactions in Acute Rheumatism
The first data to be discussed are from seventeen rheumatic subjects who developed rheumatic fever following hemolytic streptococcus pharyngitis during the winter and spring of 1938. Four of these attacks were mild, five of moderate intensity, five severe, and three were of extreme intensity. Illustrative patients are listed in Table I , in order of increasing severity.
This group includes those patients who had rheumatic attacks in 1938 from whom sera were obtained before the onset of symptoms. They were quiescent rheumatic subjects who had been under our observation for a number of years. They were selected for study at this time because each had contracted a bacteriologically proven streptococcal pharyngitis. All but one showed precipitins during the acute attack to an antigen present in their own serum just before the 31 35 P h a s e I P o t e n t i a l a n t i g e n s t a k e n d u r i n g onset of the attack. Sera taken at 2 to 3 day intervals showed that the concentration of antigen was maximal just before the symptoms appeared and that it disappeared within 3 days thereafter. In five cases enough sera were obtained before the onset of rheumatism to establish the fact that the antigens with which the above precipitins reacted were not present during pharyngitis but appeared in phase II. In one of these cases sera taken during the month preceding pharyngitis were also free of antigen. The precipitin appeared in each case during the peak of the rheumatic cycle and disappeared with subsidence. The most intense reactions were observed in sera from the severest attacks. One individual with rapidly fatal fulminating rheumatism gave the strongest precipitin reaction of all cases studied.
Precipitin Reactions Following Uncomplicated Streptococcus Infections without Rheumatism
All the patients presented in Table I had had hemolytic streptococcus pharyngitis. The possibility that the precipitin reaction was associated with pharyngitis rather than rheumatism was therefore investigated. In order to determine the serological behavior of patients who recovered from hemolytic streptococcus without developing rheumatism, two control groups were studied. These consisted of twenty non-rheumatic subjects and twenty-seven rheumatic subjects with uncomplicated respiratory infections. Sera obtained during the first 21 days after infection were tested as potential antigens, and sera obtained thereafter as potential antibodies.
The results of these tests were negative except in three patients who developed precipitins 4 to 5 weeks after infection. In one of these the antibody serum reacted only with serum from the period of acute infection (phase I). In the other two the antibody sera reacted with serum taken 2 weeks after infection; that is, their serological behavior was similar to that seen in the rheumatic group. It is of interest that, of these two, one had to be readmitted to the hospital because of abdominal pain accompanied by a high sedimentation rate. This occurred at the time that the precipitins were present.
The second control group consisted of twenty-seven rheumatic subjects under close observation who contracted hemolytic streptococcus pharyngitis but escaped all clinical and laboratory signs of rheumatic activity. The sera were assigned to serve as antigens or antibodies 
just as in the preceding group. The positive results of the precipitin tests are presented in Table II . The results of these tests were negative in twenty-two cases. These are omitted from the table. The five positive cases developed precipitins to some substance present during the acute infection and for the next 2 weeks. None of the precipitating sera were positive to phase II (the time corresponding to the symptom-free period) unless they were also positive to phase I (acute infection). These precipitins remained strong in three patients for at least 2 months after infection, in the absence of all symptoms. This type of reaction appeared on further investigation to be distinct from that of acute rheumatism (see page 158).
Precipitin Reactions in Patients with Polycyclic Courses
The data presented so far were confined to the first cycle of acute rheumatism, and in most cases it was clear that the precipitin present at the height of the cycle decreased as disease activity subsided. The next point investigated was whether precipitating sera would recur with repeated cycles of rheumatic activity. It was found that sera taken at the height of cycle II contained good precipitins for phase II antigen. The data are presented in Table III .
It will be noted in Table III that precipitins for phase II antigen recurred during the second cycle of rheumatic activity. It will also be observed that precipitins disappeared from the sera during the periods of remission between cycles of activity. When these remission sera which did not contain antibody were retested as antigens against known positive cycle II antibodies, precipitation was once more observed. The occurrence of antigen during a remission between cycles is illustrated in Table IV. Antibodies appearing in cycles I and II both precipitated phase II antigen. Furthermore, antibodies appearing in cycle II precipitated antigens developed during the remission between cycles. To demonstrate the identity of the phase II and remission antigens, it was necessary only to show that remission antigens would form a precipitate with cycle I antibody sera, which preceded them in time. The reactions of remission antigens with antibodies which preceded and followed are given in Table IV. The data in Tables III and IV leave no doubt that the antigens of phase II and remission sera are of similar reactivity.
It has often been observed that a rheumatic subject can escape an attack 3 weeks after hemolytic streptococcus infection, only to develop acute rheumatism some weeks later, at the time that a second cycle would ordinarily be anticipated. One patient in our 1938 series behaved in this manner. Sera were collected from the onset of pharyngitis, and the patient was kept under close observa- tion in the hospital. So far as could be determined, she escaped all evidences of rheumatic activity for 6 weeks after the infection, and then developed a mild but definite attack of acute rheumatism. During the first month after infection, it appeared that the patient had escaped rheumatism and we were unable to detect either antigen or antibody. However, she did develop an attack at a time which would ordinarily correspond with a second cycle. Coincident with this, precipitins appeared to serum taken one week before the onset of symptoms. The findings on this patient are given in Table V .
Experiments Dealing with Cross-Reactions between Patients
All the reactions reported so far occurred between sera of different dates from the same patient (hereafter termed homologous sera). The next point investigated was whether these reactions could be duplicated between antigens and antibodies from different patients Table VIa . Table VIa shows that heterologous sera gave precipitation reactions of approximately the same intensity as homologous sera when tested against the same known antigens or antibodies. The reactions are therefore not patient-specific. This point was further studied by checking the development of precipitinogen in phase II. The earliest positive antibody serum from each of two patients was tested against potential antigen sera from one of them. In both cases positive reactions occurred with a single antigen serum, taken 14 days after the onset of pharyngitis. The negative antigens were negative to both homologous and heterologous antibody. The data are summarized in Table VI b. A similar experiment was run in which the development of precipitin in phase III was determined by tests with three different antigens. As can be seen in Table VIc when a number of antibody sera from one patient were tested against positive homologous and heterologous antigens, differences in the intensity of reaction were apparent. These differences seemed to reflect differences in the strength of the antigens. All the antibody sera referred to in Table VI were known to contain precipitin from preliminary positive reactions with their own sera. The next subject of inquiry was whether sera from all patients with acute rheumatism would precipitate known positive antigen sera. To test this point, antigen sera from the two patients in Table  VIb were set up against the sera of nine patients with acute rheumatism. Two sera taken some days apart were tested from each patient, to ensure at least one at an appropriate time in the rheumatic cycle. The results are detailed in Table VII. The series given in Table VII consists of nine unselected cases of acute rheumatism admitted to the hospital wards some time after the onset of symptoms. No homologous antigens were available. The sera of eight of these patients contained precipitins for heter- Tables V to VII , inclusive, indicate that this precipitation reaction is not patient-specific, but will occur between sera of any rheumatic patients provided that such sera represent appropriate stages of the disease.
Experiments Dealing with the Specificity of the Reactions for Rheumatic Fever
The foregoing data have indicated that during post-streptococcal convalescence, the precipitin reaction occurred only in acute rheumatism with the exceptions discussed. We have just shown that the reaction is not patient-specific. Whether it is disease-specific was next investigated.
First it was ascertained that normal sera were consistently negative to one another and to the sera of acute rheumatism at all stages of disease activity. ~ Then it was found that neither fever nor rapid blood sedimentation paralleled the occurrence of the precipitin reaction. Sera taken during high fevers (associated with tonsillitis, lymphosarcoma, leukemia, tuberculosis, undulant fever) and sera from rapidly sedimenting bloods (associated with post-streptococcM acute nephritis, pneumonia and tuberculosis) were consistently negative to phase II antigen. Reactions did not occur when either antigen or antibody was replaced by serum from other acute febrile diseases.
Another possibility investigated was that this reaction might be related to the non-specific precipitation of pneumococcus C substance reported to occur in acute rheumatism by Tillett and Francis (11) . The sera from seven patients with acute rheumatism were found to contain strong precipifins for a 1 : 50,000 dilution of pneumococcus C. It was also found that, with one exception, the sera of twenty patients who were recovering from streptococcal throat infections but who did not have acute rheumatism, failed to precipitate pneumococcus C substance. These observations supported the possibility that the precipitin reaction might be related to the precipitation of pneumococcus C substance. If such were the case, it should be possible to establish (1) that phase II antigen reacts with antipneumococcus sera and (2) that the precipitin of phase III antibody for phase II antigen should be removed by absorption with pneumoThe sera of one patient who developed acute rheumatism in the 6th month of pregnancy showed completely divergent behavior. They gave strong positive reactions with all homologous sera, with heterologous rheumatic sera, with normal sera, even with rabbit sera. As the same thing was found to be true for normal pregnancies, this case has been eliminated from the present discussion.
coccus C substance. Experiments on these points were therefore set up:--1. Known positive phase II antigens were tested with sera from four patients with lobar pneumonia and with horse and rabbit antipneumococcus sera. These pneumonia sera precipitated C substance but did not precipitate the rheumatic phase II antigens.
2. Positive phase III sera from four cases of acute rheumatismwere treated with pneumococcus C. Following absorption, they failed to precipitate C substance but still precipitated rheumatic phase II antigens, both homologous and heterologous. An illustrative protocol is seen in Table VIII . Low Apr. 14 +a= + +a= + + + * Weakening of the pneumococcus C reaction in sera subjected to absorption with saline was observed repeatedly. Simple dilution of serum with saline, however, did not produce this effect.
These two findings indicate that the precipitin reactionof rheumatic fever is not related to the non-specific pneumococcus C reaction common to a number of febrile diseases.
The Relation of the Rheumatic Precipitin Reaction to Streptococcal
Derivatives The next experiment was done to determine whether the precipitin to phase II antigen was an antistreptococcal immune body. This was investigated in two different ways: (A) by testing known positive phase III antibody sera for antibodies to various well known fractions of hemolytic streptococcus; and (B) by testing known positive phase II sera for streptococcus antigens.
Five known positive phase III antibodies were each tested against the following streptococcus fractions: C (group-specific carbohydrate), P (nucleoprotein) and M substance of the same type as the patients' throat culture taken during phase I. Three of the sera were negative to C, and two others to P, indicating that in certain patients anti-C and anti-P are not involved in the observed precipitin reaction. The data are presented in Table IX a.
All of the antibody sera contained anti-M at some timeduring phase III; however, the reactions of phase III antibody with M substance did not parallel their reactions with phase II antigen (five cases examined). This suggested but did not prove the independence of rheumatic precipitin and anti-M. Phase III antibody sera from four cases were therefore absorbed, each with its own type-specific M substance (previously determined from throat culture isolated during phase I) to determine whether the precipitin to phase II antigen could thereby be removed. Following absorption the phase III sera no longer precipitated M substance but did still precipitate phase II antigen. A typical experiment is presented in Table IX b. Secondly, known positive phase II antigens were tested with four antistreptococcal therapeutic sera known to contain antitoxin, anti-P and anti-C. These reactions were all negative. Similar tests were performed on antigens from the same patients whose throat infections had been typed, using type-specific anti-M rabbit sera. The results were again negative as seen in Table X .
These findings indicate that the phase II antigen is not one of the four streptococcal products investigated. Phase III sera contain several antibodies to hemolytic streptococcus; but the precipitin to 
The Nature of Positive Reactions in Rheumatic Subjects Who Escaped Rheumatic Attacks
It was seen in Table II that a few individuals who escaped rheumatic attacks nevertheless developed antibodies in phase III (page 148). These sera precipitated all those which preceded them, not only phase II but also phase I. In other words, the antigen involved was already present during phase I. The question raised by these patients was whether the precipitin of these phase III sera was the same as the precipitin in phase III sera of rheumatic subjects who developed attacks. To throw light on this problem, the sera in question were tested with known positive antigens of patients who had developed attacks. The results are shown in Table XI .
From Table XI it is seen that the precipitin observed in these two patients was distinct from the precipitin which followed the development of acute rheumatism.
The Nature of Negative Reactions
The next point to be investigated was the reason for the negative reactions observed between pairs of homologous sera taken during recovery from throat infections. In these cases, where both sera were of unknown character, failure to form a precipitate may have been due to the absence of antigen, or antibody, or both; or to their presence in unsuitable proportions. Accordingly potential antigens and potential antibodies which had been negative to their homologous sera were retested against known positive antibodies and antigens, respectively, to determine which of the essentials of a positive reaction was missing.
A. Negative Reactions in Rheumatic Subjects Who Escaped A ttacks.--
Antibodies.--The first experiment of this type was set up to retest the precipitating power of two potential antibody sera from four rheumatic subjects who recovered from pharyngitis without developing acute rheumatism. Eight of these sera were tested with four known positive phase II antigen sera. The results shown were negative, indicating that antibodies to phase II antigen were absent from all of eight sera reexamined.
Antigens.--Ten potential antigen sera which had been negative to homologous sera collected about 4 weeks after infection, were retested with known positive rheumatic antibodies. The data are presented in Table XII . Half of these rheumatic subjects, who escaped attacks and who did not produce precipitins, nevertheless developed some antigen which could be precipitated by known positive heterologous antibodies. Antigens.--It has been previously shown that some rheumatic subjects who escaped rheumatism following hemolytic streptococcus infections developed antigen without forming antibodies to it. The next experiment was done to determine whether in non-rheumatic subjects who showed no precipitin reaction an antigen was likewise present. Sera from ten patients taken about 2 weeks postinfection were retested with four known positive precipifins from phase III of acute rheumatism.
Of the thirty-two tests, only one gave a positive reaction. The number of cases is too small for final conclusions; but the observations suggest that non-rheumatic subjects do not develop an antigenic substance at a time corresponding to the latter part of phase II.
